Roth MKM lowered the firm’s price target on MGP Ingredients (MGPI) to $45 from $50 but keeps a Buy rating on the shares. Following the company’s Q4 results and FY25 guidance, the firm is taking a more conservative view of how the company sales and gross margin will recover, the analyst tells investors in a research note. Roth adds however that it still expects 2026 results to show improvement over 2025, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGPI:
- Closing Bell Movers: Stitch Fix jumps over 20% on earnings beat, guidance raise
- MGP Ingredients director buys $427.3K in common stock
- MGP Ingredients Directors Plan Stock Sale
- Needham consumer analysts hold an analyst/industry conference call
- MGP Ingredients price target lowered to $40 from $75 at Truist